ZyVersa Therapeutics (ZVSA) Misses Q2 EPS by 46c
Tweet
Share
E-mailGet Alerts ZVSA Hot Sheet
Join SI Premium – FREE
ZyVersa Therapeutics (NASDAQ: ZVSA) reported Q2 EPS of ($0.46).
For earnings history and earnings-related data on ZyVersa Therapeutics (ZVSA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Equirus Starts JSW Energy Ltd (JSW:IN) at Long (1)
- JPMorgan Upgrades Largan Precision Co Ltd. (3008:TT) to Overweight
- Apple suing OpenAI over alleged misappropriation of trade secrets
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
